Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: An unprecedented tandem synthesis of fluorescent coumarin-fused pyrimidines via copper-catalyzed cross-dehydrogenative C(sp3)–N bond coupling

Santosh Kumari a, S. M. Abdul Shakoor a, Sadhika Khullar b, Sanjay K. Mandal c and Rajeev Sakhuja *a
aDepartment of Chemistry, Birla Institute of Technology & Science, Pilani, Rajasthan 333031, India. E-mail: sakhuja.rajeev@gmail.com
bDepartment of Chemistry, D.A.V. University, Jalandhar-Pathankot National Highway, Jalandhar-144012, Punjab, India
cDepartment of Chemical Sciences, Indian Institute of Science Education and Research Mohali, Sector 81, S.A.S. Nagar, Manuali P.O., Punjab 140306, India

Received 16th October 2018 , Accepted 16th October 2018

First published on 1st November 2018


Abstract

Correction for ‘An unprecedented tandem synthesis of fluorescent coumarin-fused pyrimidines via copper-catalyzed cross-dehydrogenative C(sp3)–N bond coupling’ by Santosh Kumari et al., Org. Biomol. Chem., 2018, 16, 3220–3228.


The authors regret that the structure of the final products 3 proposed in the paper based on detailed spectroscopic analysis was slightly different (another isomeric form) from the structure determined from a crystal structure determination for compound 3a reported in the paper (see below). The experimental data (1H NMR, 13C NMR and HRMS) documented for all the products is valid for both the possible structures and either structure is mechanistically plausible. The revised structure assignment is based on the assumption that the crystal structure determination for compound 3a is representative for all compounds.


image file: c8ob90154f-u1.tif
Therefore, in all places in the paper the structure of 3 should be replaced as shown below.


image file: c8ob90154f-u2.tif
In addition, the mechanism shown in Scheme 6 should be replaced by the revised mechanism shown below.


image file: c8ob90154f-s6.tif
Scheme 6 Plausible mechanism.

Furthermore, the compound names provided in the Experimental section are incorrect. For instance, 1-benzyl-2-phenyl-1,2-dihydro-5H-chromeno[4,3-d]pyrimidin-5-one (3a) should be replaced by 3-benzyl-2-phenyl-2,3-dihydro-5H-chromeno[4,3-d]pyrimidin-5-one (3a).

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2018
Click here to see how this site uses Cookies. View our privacy policy here.